On Tuesday, Shares of Amazon.com, Inc. (NASDAQ:AMZN), lost -1.14% to $537.48.
At AWS re:Invent, Amazon Web Services, Inc. (AWS), an Amazon.com company (AMZN), introduced three new AWS Partner Network (APN) Competencies that enable and promote partners who have demonstrated expertise and proven success in DevOps, Cloud Migration, and Internet of Things (IoT). In addition, AWS declared the 2016 Premier Consulting Partners, a designation that recognizes 46 APN partners that provide superior customer service and expertise in building and migrating customer solutions on AWS. AWS also declared that AWS Marketplace has grown to more than 2,300 software listings that are pre-configured for the AWS Cloud and available across 35 different categories that customers can purchase and launch, many with 1-Click functionality.
With the continued adoption of AWS services across geographies, industries, and organizations of all sizes, customers are increasingly relying on tens of thousands of APN Partners across the globe for deep expertise, specialized technology, and proven success to assist them move to the AWS Cloud for a wide range of applications and initiatives. These customers are turning to the APN Competency Program to find complete solutions, and enabling products across categories that comprise Big Data, Security, Storage, Digital Media, Healthcare, Life Sciences, Microsoft Solutions, SAP Solutions, Oracle Solutions, Marketing & Commerce, and Mobile. AWS customers are also turning to AWS Marketplace for their software needs, and recently customers around the world are using 143 million hours of Amazon Elastic Compute Cloud (Amazon EC2) each month to run AWS Marketplace products.
Amazon.com, Inc. (Amazon.com) is an e-commerce company. The Company sells a range of products and services through its Websites. The Company’s products are offered through consumer-facing Websites, which include merchandise and content that it purchases for resale from vendors and those offered by third-party sellers. It designs its Websites to enable products to be sold by the Company and by third parties across various product categories.
Shares of Illumina, Inc. (NASDAQ:ILMN), declined -10.64% to $145.81, during its last trading session.
Illumina, declared the launch of new TruSeq® library preparation kits and Infinium® arrays that enable researchers to explore genetic variation on a more comprehensive scale. The new additions to the application-driven portfolio address a broad range of genetic studies from whole exome to population and disease specific genotyping, leveraging the Illumina industry-leading portfolio of genomic analysis systems. Illumina will highlight these new genomic solutions at the 2015 American Society of Human Genetics meeting on October 6 - 10 at Booth #411.
The following new products are intended for use with Illumina next-generation sequencing (NGS) systems and are complemented by new data analysis applications available on Illumina’s BaseSpace cloud computing platform.
Illumina, Inc. is engaged in production development of sequencing-and array-based solutions for genetic analysis. The Company offers integrated systems, consumables and analysis tools for genetic analysis.
Shares of Annaly Capital Management, Inc. (NYSE:NLY), declined -0.10% to $10.18, during its last trading session.
Annaly Capital Management, has received a consensus rating of “Hold” from the eleven analysts that are presently covering the stock, MarketBeat reports. One analyst has rated the stock with a sell recommendation, five have given a hold recommendation, three have given a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year price target among analysts that have covered the stock in the last year is $10.94.
Annaly Capital Management, Inc. is a mortgage real estate investment trust (REIT). The Company uses its capital coupled with borrowed funds to invest in real estate related investments, earning the spread between the yield on its assets and the cost of its borrowings.
Finally, Nu Skin Enterprises, Inc. (NYSE:NUS), ended its last trade with 1.48% gain, and closed at $46.53.
Nu Skin Enterprises, updated its revenue guidance for the third quarter of 2015 in advance of this week’s global sales leader convention. The company estimates third-quarter revenue in a range of $570 to $573 million, about even with the prior year on a constant-currency basis. Foreign currency headwinds associated with the strengthening of the U.S. dollar negatively influenced revenue by more than $60 million contrast to the prior-year period. The revised revenue range is predictable to represent continued improvement on a sequential basis, and the company continues to forecast constant-currency revenue growth in the fourth quarter of 2015 as compared to the prior year.
The Nu Skin administration team plans to release third quarter 2015 results after the market closes on Nov. 5, 2015 and will host a conference call with the investment community on Nov. 5, 2015, at 5 p.m. (EST) to discuss these results.
Nu Skin Enterprises, Inc. is a global direct selling company marketing personal care and nutritional products in 53 markets worldwide. The Company develops and distributes anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands, respectively.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
